Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Baxter: 3 Key Takeaways for Long-Term Investors

Over 700 process improvements year-to-date may help expand margins without added capital, a rare efficiency gain in a manufacturing turnaround.

Baxter's CFO, John Rogers, emphasized that lowering net leverage remains the company's top priority before considering potential business acquisitions. The financial executive stated that reducing leverage is the primary near-term capital allocation focus, and the company's actions thus far have bolstered confidence in achieving a net leverage target of around three times by the end of the year.

In its ongoing efforts to streamline operations and improve efficiency, Baxter completed over 700 process initiatives year to date. The internal operating system, known as Baxter GPS, contributed to reducing manufacturing cycle times for blood pressure cuffs by over 10% without the need for additional capital investment. The company's President and CEO, Andrew Hider, highlighted the cumulative value of these incremental improvements in driving better operating and financial performance over time.

Baxter's third-quarter 2026 earnings call, held on October 29, 2026, saw management announce revised guidance for full-year organic sales growth and adjusted earnings. The company's operational turnaround is reflected in higher cash flows and improved execution, following recent manufacturing challenges. Management has decided to cease production of cephalosporin antibiotics at its Round Lake, Illinois facility to simplify operations and address regulatory concerns raised by the FDA in a recent warning letter.

This strategic shift aims to mitigate manufacturing complexities, eliminate potential supply shortages, and enhance operational flexibility by focusing solely on non-antibiotic products.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at fool.com →

More in Finance & Markets

CoinShares (CSHR) Q3 2026 Earnings Call Transcript

Inflows accelerate and a $40 million buyback signals confidence in the rebound.

  • CoinShares reported Q3 2026 earnings with recovered AUM at start-of-year levels
  • Segment EBITDA margin reached 56% due to fixed cost structure
  • Company acquired Bastion Asset Management and authorized $40M share repurchase

John B. Sanfilippo: 3 Key Takeaways for Long-Term Investors

Competitor capacity exits and contract manufacturing gains are reshaping the company's margin outlook as new production lines ramp.

  • Contract manufacturing volume grew 41.3% in Q1 2027 due to replacement production.
  • New high-speed manufacturing lines planned for Q4 2027 to boost profit margins.
  • Orchard Valley Harvest (OVH) brand products gaining traction in value-focused snacking channels.

KBR: 3 Key Takeaways for Long-Term Investors

Mission Tech expanded margins despite NASA headwinds, signaling operational discipline ahead of the January split.

  • KBR's revenue grew 5% YoY to $2.03 billion in Q3 2026
  • Commercial technology division drove growth with expanding margins
  • Sustainable Tech backlog increased 50% YoY, providing multiyear visibility

More from Wednesday 18 November →